title: Acute inhibition of ATP-sensitive K+ channels impairs skeletal muscle vascular control in rats during treadmill exercise.
abstract: The ATP-sensitive K(+) (KATP) channel is part of a class of inward rectifier K(+) channels that can link local O2 availability to vasomotor tone across exercise-induced metabolic transients. The present investigation tested the hypothesis that if KATP channels are crucial to exercise hyperemia, then inhibition via glibenclamide (GLI) would lower hindlimb skeletal muscle blood flow (BF) and vascular conductance during treadmill exercise. In 27 adult male Sprague-Dawley rats, mean arterial pressure, blood lactate concentration, and hindlimb muscle BF (radiolabeled microspheres) were determined at rest (n = 6) and during exercise (n = 6-8, 20, 40, and 60 m/min, 5% incline, i.e., ~60-100% maximal O2 uptake) under control and GLI conditions (5 mg/kg intra-arterial). At rest and during exercise, mean arterial pressure was higher (rest: 17 ± 3%, 20 m/min: 5 ± 1%, 40 m/min: 5 ± 2%, and 60 m/min: 5 ± 1%, P < 0.05) with GLI. Hindlimb muscle BF (20 m/min: 16 ± 7%, 40 m/min: 30 ± 9%, and 60 m/min: 20 ± 8%) and vascular conductance (20 m/min: 20 ± 7%, 40 m/min: 33 ± 8%, and 60 m/min: 24 ± 8%) were lower with GLI during exercise at 20, 40, and 60 m/min, respectively (P < 0.05 for all) but not at rest. Within locomotory muscles, there was a greater fractional reduction present in muscles comprised predominantly of type I and type IIa fibers at all exercise speeds (P < 0.05). Additionally, blood lactate concentration was 106 ± 29% and 44 ± 15% higher during exercise with GLI at 20 and 40 m/min, respectively (P < 0.05). That KATP channel inhibition reduces hindlimb muscle BF during exercise in rats supports the obligatory contribution of KATP channels in large muscle mass exercise-induced hyperemia.
authors.affiliation: Department of Anatomy and Physiology, Kansas State University, Manhattan, Kansas; and clark40@k-state.edu.
authors.forename: Clark T
authors.initials: CT
authors.lastname: Holdsworth
authors.affiliation: Department of Anatomy and Physiology, Kansas State University, Manhattan, Kansas; and.
authors.forename: Steven W
authors.initials: SW
authors.lastname: Copp
authors.affiliation: Department of Anatomy and Physiology, Kansas State University, Manhattan, Kansas; and.
authors.forename: Scott K
authors.initials: SK
authors.lastname: Ferguson
authors.affiliation: Department of Kinesiology, Kansas State University, Manhattan, Kansas.
authors.forename: Gabrielle E
authors.initials: GE
authors.lastname: Sims
authors.affiliation: Department of Anatomy and Physiology, Kansas State University, Manhattan, Kansas; and Department of Kinesiology, Kansas State University, Manhattan, Kansas.
authors.forename: David C
authors.initials: DC
authors.lastname: Poole
authors.affiliation: Department of Anatomy and Physiology, Kansas State University, Manhattan, Kansas; and Department of Kinesiology, Kansas State University, Manhattan, Kansas.
authors.forename: Timothy I
authors.initials: TI
authors.lastname: Musch
mesh_terms: D000818:Animals; D062186:Arterial Pressure; D005905:Glyburide / Q000494:pharmacology*; D006940:Hyperemia / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D018482:Muscle, Skeletal / Q000098:blood supply* / Q000187:drug effects / Q000378:metabolism; D005082:Physical Exertion; D051381:Rats; D017207:Rats, Sprague-Dawley; D012039:Regional Blood Flow; D064233:Sulfonylurea Receptors / Q000037:antagonists & inhibitors*
chemical_list: D064233:Sulfonylurea Receptors; D005905:Glyburide
keywords: blood flow; conductance; glibenclamide
references.citation: Diabetes Care. 1999 Oct;22(10):1647-54
references.pmid: 10526729
references.citation: J Cardiovasc Electrophysiol. 2003 Jan;14(1):94-103
references.pmid: 12625619
references.citation: J Physiol. 2004 Nov 15;561(Pt 1):273-82
references.pmid: 15345750
references.citation: J Appl Physiol (1985). 2006 May;100(5):1506-12
references.pmid: 16469932
references.citation: J Physiol. 2006 May 1;572(Pt 3):617-24
references.pmid: 16484295
references.citation: Respir Physiol Neurobiol. 2007 May 14;156(2):187-95
references.pmid: 17015044
references.citation: Exp Physiol. 2007 Mar;92(2):341-6
references.pmid: 17185349
references.citation: FASEB J. 2007 Jul;21(9):2162-72
references.pmid: 17341678
references.citation: Diabetes Obes Metab. 2008 Mar;10(3):238-45
references.pmid: 18269639
references.citation: J Physiol. 2009 Feb 15;587(Pt 4):713-9
references.pmid: 19218620
references.citation: Am J Physiol Regul Integr Comp Physiol. 2010 Feb;298(2):R478-85
references.pmid: 20007515
references.citation: J Pharmacol Exp Ther. 2011 Aug;338(2):458-65
references.pmid: 21558438
references.citation: Am J Physiol Regul Integr Comp Physiol. 2011 Sep;301(3):R783-90
references.pmid: 21677269
references.citation: J Physiol. 2012 Dec 15;590(24):6297-305
references.pmid: 22988140
references.citation: Cardiovasc Drugs Ther. 2000 Feb;14(1):23-9
references.pmid: 10755197
references.citation: Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H22-33
references.pmid: 11123214
references.citation: Am J Physiol Heart Circ Physiol. 2012 Mar 1;302(5):H1050-63
references.pmid: 22101528
references.citation: Am J Physiol. 1980 Oct;239(4):H443-H449
references.pmid: 7425136
references.citation: Eur J Clin Pharmacol. 1990;38(1):93-5
references.pmid: 2109700
references.citation: Nature. 1990 Jul 5;346(6279):69-71
references.pmid: 2366864
references.citation: Am J Physiol. 1990 Jul;259(1 Pt 1):C3-18
references.pmid: 2164782
references.citation: Am J Physiol. 1992 Feb;262(2 Pt 2):H411-9
references.pmid: 1539701
references.citation: Am J Physiol. 1993 Nov;265(5 Pt 2):H1797-803
references.pmid: 8238593
references.citation: Br J Pharmacol. 1993 Oct;110(2):573-82
references.pmid: 8242232
references.citation: Br J Pharmacol. 1993 Oct;110(2):583-90
references.pmid: 8242233
references.citation: Am J Physiol. 1994 Jan;266(1 Pt 2):H43-51
references.pmid: 8304522
references.citation: Br J Pharmacol. 1994 Jun;112(2):649-53
references.pmid: 8075883
references.citation: Cardiovasc Res. 1994 Jun;28(6):805-10
references.pmid: 7923283
references.citation: J Appl Physiol (1985). 1994 Jul;77(1):127-34
references.pmid: 7961224
references.citation: Circ Res. 1995 Jan;76(1):53-63
references.pmid: 8001278
references.citation: J Appl Physiol (1985). 1994 Sep;77(3):1288-93
references.pmid: 7530705
references.citation: Biol Pharm Bull. 1994 Oct;17(10):1341-4
references.pmid: 7874055
references.citation: Am J Physiol. 1995 Mar;268(3 Pt 2):H1077-85
references.pmid: 7900861
references.citation: Am J Physiol. 1995 Apr;268(4 Pt 1):C799-822
references.pmid: 7733230
references.citation: Br J Pharmacol. 1995 Aug;115(8):1447-54
references.pmid: 8564204
references.citation: J Physiol. 1995 Jul 1;486 ( Pt 1):47-58
references.pmid: 7562643
references.citation: Am J Physiol. 1996 May;270(5 Pt 2):H1649-54
references.pmid: 8928870
references.citation: J Appl Physiol (1985). 1996 Jan;80(1):261-70
references.pmid: 8847313
references.citation: Br J Pharmacol. 1996 Feb;117(3):507-515
references.pmid: 8821541
references.citation: Am J Physiol. 1996 Sep;271(3 Pt 2):F653-8
references.pmid: 8853428
references.citation: Diabetologia. 1996 Sep;39(9):1083-90
references.pmid: 8877293
references.citation: Am J Physiol. 1996 Oct;271(4 Pt 2):H1594-8
references.pmid: 8897956
references.citation: Diabetologia. 1996 Dec;39(12):1562-8
references.pmid: 8960843
references.citation: J Clin Invest. 1997 Jun 1;99(11):2602-9
references.pmid: 9169489
references.citation: J Appl Physiol (1985). 1999 Aug;87(2):574-81
references.pmid: 10444615
references.citation: Am J Physiol Heart Circ Physiol. 2001 Aug;281(2):H738-44
references.pmid: 11454578
references.citation: Clin Sci (Lond). 2003 Jan;104(1):39-46
references.pmid: 12519086
references.citation: Am J Physiol Regul Integr Comp Physiol. 2003 Feb;284(2):R558-63
references.pmid: 12388475
references.citation: Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2576-84
references.pmid: 15271659